[144] Life360, Inc. SEC Filing

Rhea-AI Filing Summary

Life360, Inc. submitted a Rule 144 notice proposing the sale of 7,930 common shares through Fidelity Brokerage Services on 09/15/2025 with an aggregate market value of $794,903.20. The filing reports 77,548,651 shares outstanding. The securities were acquired on 09/15/2025 as options originally granted on 04/12/2022 and the stated payment method is cash. The form also discloses two prior sales by Charles Prober within the past three months: 7,930 shares sold on 07/14/2025 for $510,771.30 and 7,930 shares sold on 08/13/2025 for $667,150.90. The filer attests there is no undisclosed material adverse information.

Positive

• Transparent disclosure of proposed sale details including broker, share count, aggregate market value, and acquisition history
• Compliance with Rule 144 formalities and inclusion of insider attestation about undisclosed material information

Negative

• Insider sales in recent months (07/14/2025 and 08/13/2025) may indicate ongoing insider liquidity
• Limited context—the filing does not provide broader information about remaining insider holdings or any 10b5-1 plan adoption date

Insights

Securities Analyst

TL;DR Insider reports planned sale of 7,930 shares under Rule 144; prior near-term sales also disclosed, suggesting routine insider liquidity.

The filing is a standard Rule 144 notice providing transaction specifics: number of shares, acquisition date, grant date for the underlying options, payment method, and proposed sale date and venue. The disclosed sales in July and August indicate the insider has been selling shares recently. Relative to the company's reported shares outstanding of 77,548,651, the proposed sale represents a small fraction of outstanding shares, so market impact is likely minimal. The filing meets disclosure requirements and includes the customary attestation regarding material nondisclosure.

Corporate Governance Expert

TL;DR The notice documents executive share disposals and shows compliance with Rule 144 formalities; no governance red flags evident from this filing alone.

The document identifies the instrument (common stock), broker, and acquisition details (options granted 04/12/2022, acquired 09/15/2025). It affirms no known undisclosed material adverse information, which is the standard insider representation. While repeated insider sales can prompt governance questions, this filing alone does not provide context on trading plans, open-window policies, or the insider’s overall shareholding. Additional filings or company disclosures would be required to assess broader governance implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7930	794903.20	77548651	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Options Granted - 04/12/2022	Issuer			7930	09/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Charles Prober 1900 South Norfolk Street Suite 310 San Mateo CA 94403	Common	07/14/2025	7930	510771.30
Charles Prober 1900 South Norfolk Street Suite 310 San Mateo CA 94403	Common	08/13/2025	7930	667150.90

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Rule 144 notice for Life360 (LIFX) disclose?

The notice discloses a proposed sale of 7,930 common shares via Fidelity on 09/15/2025 with aggregate market value $794,903.20, acquisition from options granted on 04/12/2022, paid in cash.

How many shares of Life360 are outstanding according to the filing?

The filing reports 77,548,651 shares outstanding.

Were there recent insider sales by the same person?

Yes. The filing lists two prior sales by Charles Prober: 7,930 shares on 07/14/2025 for $510,771.30 and 7,930 shares on 08/13/2025 for $667,150.90.

How were the shares to be sold acquired?

The securities were acquired as options granted on 04/12/2022 with acquisition date shown as 09/15/2025, and the payment type indicated is cash.

Does the filing state there is undisclosed material information?

The person signing the notice represents that they do not know of any material adverse information about the issuer that has not been publicly disclosed.